- Home
- BLRX vs AQMS Comparison
BLRX vs AQMS Comparison
Compare BLRX & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLRX | AQMS |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 20.9M |
| IPO Year | 2011 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BLRX | AQMS |
|---|---|---|
| Price | $3.10 | $5.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $19.00 | $12.00 |
| AVG Volume (30 Days) | 27.3K | ★ 130.6K |
| Earning Date | 11-24-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,735,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $550.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.30 | $3.37 |
| 52 Week High | $14.70 | $39.40 |
Technical Indicators
Market Signals| Indicator | BLRX | AQMS |
|---|---|---|
| Relative Strength Index (RSI) | 42.76 | 38.38 |
| Support Level | $2.87 | $5.96 |
| Resistance Level | $3.36 | $7.61 |
| Average True Range (ATR) | 0.19 | 0.55 |
| MACD | -0.02 | -0.17 |
| Stochastic Oscillator | 41.08 | 3.72 |
Price Performance
Historical ComparisonAbout BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.